Press Release: Intellia : ROSEN, SKILLED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York--(Newsfile Corp. - March 30, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Intellia
Read full article »
Intellia Therapeutics is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases.
Read more